SHANGHAI HAOYUAN CHEMEXPRESS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.67 CNY | -3.54% |
|
-5.69% | -37.25% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Shanghai Haoyuan Chemexpress Co Ltd is a China-based company mainly engaged in the research and development, production and sales of small molecule drugs. The Company's main products include molecular building blocks and tool compounds. The Company's products also include active pharmaceutical ingredients (APIs) and intermediates. The Company also provides related services such as contract research organization (CRO) service. The Company's molecular building blocks and tool compounds are applied in all stages of the drug discovery process. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
32.67
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -37.25% | 705M | |
| -1.60% | 89.08B | |
| +2.76% | 40.9B | |
| -12.92% | 32.25B | |
| +54.69% | 25.14B | |
| -16.51% | 15.39B | |
| -8.27% | 11.91B | |
| -42.60% | 11.89B | |
| -12.82% | 11.64B | |
| +7.34% | 9.03B |
- Stock Market
- Equities
- 688131 Stock
- News Shanghai Haoyuan Chemexpress Co., Ltd.
- Haoyuan Chemexpress Posts 48% Profit Jump in 2021 on Strong Drug Development Demand